Stock Price
2.16
Daily Change
-0.03 -1.37%
Monthly
-51.89%
Yearly
-22.86%
Q2 Forecast
2.29

Acasti Pharma reported $-3.7M in EBIT for its fiscal quarter ending in December of 2024.





Ebit Change Date
Acasti Pharma USD -3.7M 1.13M Dec/2024
Addus HomeCare USD 34.07M 8.2M Mar/2026
Amarin USD -2.26M 564K Dec/2025
Cassava Sciences USD -13.55M 1.69M Dec/2025
Knight Therapeutics CAD 6.21M 3.27M Dec/2025
Option Care Health USD 72.54M 18.96M Mar/2026
Organigram Holdings CAD -20.13M 7.92M Dec/2025
Tilray USD -20.01M 9.34M Sep/2025